Make an Appointment Contact Us

The Department of Cardiothoracic Surgery is a recognized leader in heart, lung and esophagus surgery. Our experience with complex cardiothoracic issues and knowledge of the latest advances have helped to establish NewYork-Presbyterian|Weill Cornell Medicine as a major referral center for cardiovascular and thoracic patients from around the world.

Cardiac Surgery

The Division of Cardiac Surgery provides expert care to patients who need:

Coronary Artery Bypass Surgery
Valve repair/replacement
Aortic Aneurysm & Dissection Repair
Minimally Invasive & Robotic Heart Surgery
Ventricular Assist Device & Heart Transplant

Learn More

Thoracic Surgery

The Division of Thoracic Surgery offers the most advanced surgical care for:

Lung & Esophageal cancers
Thymoma
Achalasia
Hyperhidrosis
Hiatal Hernia
Lung Volume Reduction for Emphysema
Tracheobronchomalacia (TBM)

Learn More

Cardiac Surgery

Adult & Pediatric

Thoracic Surgery

Lung & Esophagus

Why Choose Weill Cornell?

Make an Appointment Refer a Patient

NewYork-Presbyterian & Weill Cornell Medicine – Cardiothoracic Surgery

New Advances

Breakthrough in Thoracic Surgery: First Single-Port Robotic Ivor-Lewis Esophagectomy in U.S.

Dr. Villena-Vargas at OR

Dr. Jonathan Villena-Vargas has achieved a significant surgical milestone by performing the first Single-Port (SP) Robotic Ivor-Lewis esophagectomy in the United States. This groundbreaking procedure represents a major advancement in minimally invasive thoracic surgery, utilizing a single incision to enhance precision while reducing patient trauma. The accomplishment highlights Weill Cornell Medicine’s leadership in surgical innovation and its commitment to improving outcomes for patients undergoing complex esophageal cancer treatment.

Non-Smoker Lung Cancer Survivor Shares Important Message

At TODAY's show, Dr. Jeffrey Port highlights the critical role of early detection in improving lung cancer outcomes and calls for expanded screening efforts that better encompass nonsmokers and other groups currently excluded from existing screening guidelines.

Click Here to Learn More

The Why Behind the Lab Coat with Dr. Nasser K. Altorki

Dr. Nasser Altorki

Watch the video to meet Dr. Nasser K. Altorki:

Instagram

Facebook

New Thoracic Clinical Trial

A Multicenter Phase II randomized trial of Neoadjvuant Radioimmunotherapy vs Chemotherapy in patients with Clinical Stages IB-III (N2) Non-Small Cell Lung Cancer (RICHIS)

Clinical Trials

The Cardiothoracic Surgery Department conducts a robust clinical trials program to evaluate the effectiveness of new treatments and medications that have the potential to improve the management of patients with heart, lung, and esophageal disease. The outcomes of heart, lung, and esophageal operations can be improved with technical innovations.